Moreover, a recent study in Thailand demonstrated high IgA and IgM false-positive rates for SARS-CoV-2 antibodies in patients with dengue and other tropical infections, limiting the use of serological assays in the diagnosis of several tropical infections during co-circulation with COVID-19 [32]. This evidence concerns the gene CD79A and COVID-19.